New HTA codes of practice In April the Human Tissue Authority (HTA) published updated Codes of practice. This guest blog by Regulation Manager, Fiona Maleady-Crowe explains what this means for Biobanks. What are the Codes of Practice? The HTA’s Codes of Practice provide practical guidance on the human tissue legislation and set out the HTA’s licensing standards. The Codes are important resources which help researchers and establishments comply with our… Read More »New HTA codes of practice
Patient data and tissue samples – benefits, barriers and concerns On 9th May, 2017, the UKCRC TDCC co-hosted the workshop ‘Patient data and tissue samples – benefits, barriers and concerns’ along with Use MY Data, Independent Cancer Patient’s Voice (ICPV) and the NCRI’s Cellular & Molecular Pathology (CM-Path) initiative. The event was a good opportunity to delve into the issues associated with tissue sample and data donation for research. Chris… Read More »Patient data and tissue samples – benefits, barriers and concerns
The immortal life of Henrietta Lacks Today, samples donated for medical research are anonymised so that any work performed on them cannot be traced back to the donor. But donation for research has not always worked like this. In 1951, tumour cells from a patient in the USA were grown and sent all over the world, later to be traced back to her and her family. We discuss the implications… Read More »The immortal life of Henrietta Lacks
UK sample resources now in the BBMRI-ERIC Directory UKCRC Tissue Directory registered sample resources are now discover-able in the BBMRI-ERIC Directory. The UKCRC TDCC represents the UK within Biobanking and BioMolecular Resources Research Infrastructure – European Research Infrastructure Consortium (BBMRI-ERIC). As part of the UKCRC TDCC’s continued commitment to prevent duplication of effort, all UKCRC Tissue Directory registered sample resources will be automatically registered in the BBMRI-ERIC Directory. The step… Read More »UK Biobanks now in the BBMRI-ERIC Directory
Cost recovery in Biobanking When patients donate samples for research they do so with goodwill as a gift to research. So why is there sometimes reference to ‘the cost of samples?’ We explain more about the use of Cost recovery in Biobanking in our latest blog. How can tissue cost money when it is donated for free? The process of getting access to a hospital, surgeon, pathologist, clinical data and… Read More »Cost recovery in Biobanking
NC3Rs Workshop: Human tissue models for cancer research On 1st and 2nd of March , the UKCRC TDCC attended the NC3Rs workshop: Human tissue models for cancer research. Here, we outline the day’s events and what we learned. The first day was opened by Prof Gareth Thomas who gave a pathologists perspective, highlighting the importance of the tumour microenvironment which means research should focus on more than studying single cells.… Read More »NC3Rs Workshop: Human tissue models for cancer research
Many Biobanks are under pressure to adopt more sustainable, business-like mentalities in the future. The results of a ISBER survey on business planning in the Biobanking community is outlined in this post.
The Health Research Authority (HRA) have published new guidance on taking a proportionate approach to consent, particularly in reference to clinical trials.
A recent study has found that only around 9% of biobanks have a publicly available access policy. Given that most biobanks are funded by the public, there is an expectation that the samples they contain are made available for external research purposes that could ultimately have a social benefit. But for this to happen, clear access policies need to govern the conditions under which samples can be used for external… Read More »Only a minority of biobanks have a publicly available access policy
Spotlight on: Gautam Mehta Job title: Honorary Consultant and Senior Lecturer, UCL Research Project: Gautam is exploring new ways to treat patients with liver failure and alcohol-related liver disease. Liver disease is the third commonest cause of preventable death in the UK and rates are rising rapidly, therefore new treatments are urgently needed. Gautam’s research involves sequencing RNA (part of the genetic code of cells) from human liver and immune cells… Read More »Spotlight on: Gautam Mehta